CDC (Centres for Disease Control and Prevention): Influenza
CDC works 24/7 to protect America from health, safety and security threats, both foreign and in the U.S. Whether diseases start at home or abroad, are chronic or acute, curable or preventable, human error or deliberate attack, CDC fights disease and supports communities and citizens to do the same.
European Union Summary Report on Trends and Sources of Zoonoses, Zoonotic Agents and Food-borne Outbreaks in 2013
The report presents the results of the zoonoses monitoring activities carried out in 2013 in 32 European countries:eg 28 Member States (MS) and four non-Member States (non-MS) European Free Trade Association (EFTA) countries.
Antimicrobial resistance surveillance in Europe 2014
This report presents antimicrobial resistance data for seven microorganisms of major public health importance: Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter species, Streptococcus pneumoniae, Staphylococcus aureus, and Enterococci.
Molecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA – January 2016
This report describes the geographical and temporal distribution of multidrug-resistant tuberculosis based on molecular typing data (24-locus MIRU–VNTR genotyping) as reported by EU/EEA countries.
The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2015
European Union summary report based on data on antimicrobial resistance in zoonotic and indicator bacteria in 2015, submitted by 28 EU Member States (MSs), jointly analysed by EFSA and ECDC.
Molecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA
This report describes the geographical and temporal distribution of multidrug-resistant (MDR) tuberculosis (TB) using molecular typing data reported by European Union (EU)/European Economic Area (EEA) Member States for 2015 and the preceding years.
ECDC study protocol for genomic-based surveillance of carbapenem-resistant and/or colistin-resistant Enterobacteriaceae at the EU level
This ECDC study protocol describes the technical requirements for implementing future EU-level genomic-based surveillance of carbapenem-resistant and/or colistin-resistant Enterobacteriaceae.